| BACC (%) | Sensitivity (%) | Specificity (%) | Significance (p-value) | Median number of alpha-values used |
---|---|---|---|---|---|
Dataset 1 | Â | Â | Â | Â | Â |
CD4-Diversity \( \left(\overrightarrow{{}^{\alpha }D}\right) \): Month 2 versus Baseline + Month 12 | 86.5 | 72.9 | 100 | 0 | 8 |
CD4-Evenness \( \left(\overrightarrow{{}^{\alpha }E}\right) \): Month 2 versus Baseline + Month 12 | 91.7 | 83.3 | 100 | 0 | 11 |
CD8-Diversity \( \left(\overrightarrow{{}^{\alpha }D}\right) \): Month 2 versus Baseline + Month 12 | 79.2 | 58.3 | 100 | 0 | 9 |
CD8-Evenness \( \left(\overrightarrow{{}^{\alpha }E}\right) \): Month 2 versus Baseline + Month 12 | 96.9 | 93.8 | 100 | 0 | 6 |
Dataset 2 | |||||
Diversity: Healthy versus CLL \( \left(\overrightarrow{{}^{\alpha }D}\right) \) | 88 | 77 | 100 | 0 | 5 |
Evenness: Healthy versus CLL \( \left(\overrightarrow{{}^{\alpha }E}\right) \) | 84 | 77 | 91 | 0 | 2 |